Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Single-dose and multiple-dose administration of indole-3-carbinol to women: pharmacokinetics based on 3,3'-diindolylmethane.

Reed GA, Arneson DW, Putnam WC, Smith HJ, Gray JC, Sullivan DK, Mayo MS, Crowell JA, Hurwitz A.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2477-81.

2.

Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene, a third generation selective estrogen receptor modulator.

Fabian CJ, Kimler BF, Anderson J, Tawfik OW, Mayo MS, Burak WE Jr, O'Shaughnessy JA, Albain KS, Hyams DM, Budd GT, Ganz PA, Sauter ER, Beenken SW, Grizzle WE, Fruehauf JP, Arneson DW, Bacus JW, Lagios MD, Johnson KA, Browne D.

Clin Cancer Res. 2004 Aug 15;10(16):5403-17.

3.

A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.

Fabian CJ, Kimler BF, Brady DA, Mayo MS, Chang CH, Ferraro JA, Zalles CM, Stanton AL, Masood S, Grizzle WE, Boyd NF, Arneson DW, Johnson KA.

Clin Cancer Res. 2002 Oct;8(10):3105-17.

4.
5.

Application of microencapsulation technology to improve the stability of citral in rodent diets.

Kuhn GO, McCampbell P, Singmaster G, Arneson DW, Jameson CW.

Fundam Appl Toxicol. 1991 Oct;17(3):635-40.

PMID:
1794663
6.
7.

Toxicology studies of a chemical mixture of 25 groundwater contaminants. I. Chemistry development.

Yang RS, Goehl TJ, Brown RD, Chatham AT, Arneson DW, Buchanan RC, Harris RK.

Fundam Appl Toxicol. 1989 Oct;13(3):366-76.

PMID:
2612771
8.

Supplemental Content

Loading ...
Support Center